The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Open accessAbstract
For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biology of the prion diseases. Recently, owing largely to the advent of new disease models, this hypothesis has gained experimental momentum. In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid. Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease. Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin. However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function. As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The recent discovery that specific misfolded and aggregated proteins can propagate and spread in a prion-like fashion has sparked considerable interest (67).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In Parkinson’s disease and Lewy body disease, α-synuclein aggregates initially spread through the brainstem and olfactory bulb followed by limbic structures, and only thence to the neocortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In each of these cases, the aggregates initially deposit at the ventral base of the forebrain and midbrain, and then extend rostrally and dorsally to the cortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“While still a contentious topic [46], there is now substantial evidence that also supports the idea that propagation of pathological tau species occurs between cells [47–50].”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [50]
In the citing paper
“As aforementioned, the neuropathological lesions of not only AD but also PD/DLB and amyotrophic lateral sclerosis (ALS) are known to spread through the brain in a rather specific pattern, which also serves as a basis for the neuropathological staging of disease severity [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“Importantly, the spatiotemporal spread of αSyn lesions in PD/DLB is nearly inverted to the spread of Aβ and tau pathology as observed in AD [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“pathological neurofibrillary Tau aggregates show a pattern of accumulation that starts in the entorhinal cortex and spreads through connected pathways to cortical areas (Jucker and Walker, 2013)”
From Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease (2020) · cites this paper as Jucker and Walker, 2013
In the citing paper
“It has been suggested that alpha-synuclein could act like a prion protein during PD pathogenesis.In this theory pathologic, misfolded alpha-synuclein is an 'infectious' protein spreading pathology by forming a template that seeds misfolding for nearby alpha-synuclein protein, turning the previously healthy protein into a pathogenic protein (Jucker and Walker, 2013;Visanji et al., 2013).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Jucker and Walker, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Molecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Glymphatic system dysfunction in neurodegenerative diseases
Beschörner, N., & Nedergaard, M. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001252 · Cited by 60
VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates
Wang, C., Zhang, K., Cai, B., Haller, J. E., Carnazza, K. E., Hu, J., Zhao, C., Tian, Z., Hu, X. Y., Hall, D., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01456-1 · Cited by 64
Zheng, Y., Joo, H., Nair, V., LE, K. Y., & Otto, M. J. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.08.010 · Cited by 60
Systemic Immune Response to Traumatic CNS Injuries—Are Extracellular Vesicles the Missing Link?
Yates, A. G., Anthony, D. C., Ruitenberg, M. J., & Couch, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02723 · Cited by 60
TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson’s Disease
Zhu, G., Harischandra, D. S., Ghaisas, S., Zhang, P., Prall, W., Huang, L., Maghames, C. M., Guo, L., Luna, E., Mack, K. L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108418 · Cited by 61
Aubrey, L. D., Blakeman, B. J. F., Lutter, L., Serpell, C. J., Tuite, M. F., Serpell, L. C., & Xue, W. (2020) · Communications Chemistry · doi:10.1038/s42004-020-00372-3 · Cited by 60
Arotçarena, M.-L., Soria, F. N., Cunha, A., Doudnikoff, É., Prévot, G., Daniel, J., Blanchard-Desce, M. H., Barthélémy, P., Bézard, E., Crauste–Manciet, S., et al. (2022) · Aging Cell · doi:10.1111/acel.13584 · Cited by 60
Ex vivo mammalian prions are formed of paired double helical prion protein fibrils
Terry, C., Wenborn, A., Gros, N., Sells, J., Joiner, S., Hosszu, L. L. P., Tattum, M. H., Panico, S., Clare, D. K., Collinge, J., et al. (2016) · Open Biology · doi:10.1098/rsob.160035 · Cited by 59
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases
Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 60
Self-citationNanoEHS beyond toxicity – focusing on biocorona
Lin, S., Mortimer, M., Chen, R., Käkinen, A., Riviere, J. E., Davis, T. P., Ding, F., & Ke, P. C. (2017) · Environmental Science Nano · doi:10.1039/c6en00579a · Cited by 60
Cause and consequence of Aβ – Lipid interactions in Alzheimer disease pathogenesis
Rangachari, V., Dean, D. N., Rana, P., Vaidya, A., & Ghosh, P. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.004 · Cited by 61
Liebelt, F., Sebastian, R. M., Moore, C. L., Mulder, M. P. C., Ovaa, H., Shoulders, M. D., & Vertegaal, A. C. O. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.027 · Cited by 59
Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway
Marshall, K. E., Vadukul, D. M., Staras, K., & Serpell, L. C. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03464-4 · Cited by 61
Vilette, D., Laulagnier, K., Huor, A., Alais, S., Simoes, S., Romao, M., Provansal, M., Lehmann, S., Andréoletti, O., Schaeffer, L., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1945-8 · Cited by 65
The HET-S/s Prion Motif in the Control of Programmed Cell DeathPreprint
Riek, R., & Saupe, S. J. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023515 · Cited by 60
Persistence of Aβ seeds in APP null mouse brain
Ye, L., Fritschi, S. K., Schelle, J., Obermüller, U., Degenhardt, K., Kaeser, S. A., Eisele, Y. S., Walker, L. C., Baumann, F., Staufenbiel, M., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4117 · Cited by 58
Self-citationG ut F eelings Ab out α‐ S ynuclein in G astrointestinal B iopsies: B iomarker in the M aking?
Ruffmann, C., & Parkkinen, L. (2016) · Movement Disorders · doi:10.1002/mds.26480 · Cited by 60
Parkinson’s disease as a multisystem disorder
Klingelhoefer, L., & Reichmann, H. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1692-0 · Cited by 63
The Cell Biology of Tau Secretion
Merezhko, M., Uronen, R., & Huttunen, H. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.569818 · Cited by 65
The Digital Brain Bank, an open access platform for post-mortem imaging datasets
Tendler, B. C., Hanayik, T., Ansorge, O., Bangerter-Christensen, S., Berns, G. S., Bertelsen, M. F., Bryant, K., Foxley, S., van den Heuvel, M. P., Howard, A. F. D., et al. (2022) · eLife · doi:10.7554/elife.73153 · Cited by 57
In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
Tiiman, A., Krishtal, J., Palumaa, P., & Tõugu, V. (2015) · AIP Advances · doi:10.1063/1.4921071 · Cited by 62
ADSC Therapy in Neurodegenerative Disorders
Chan, T.-M., Chen, J. Y.-R., Ho, L.-I., Lin, H.-P., Hsueh, K.-W., Liu, D. D., Chen, Y.-H., Hsieh, A.-C., Tsai, N., Hueng, D., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x678445 · Cited by 57
Progression of Seed‐Induced A β Deposition within the Limbic Connectome
Ye, L., Hamaguchi, T., Fritschi, S. K., Eisele, Y. S., Obermüller, U., Jucker, M., & Walker, L. C. (2015) · Brain Pathology · doi:10.1111/bpa.12252 · Cited by 60
Self-citationFornari, S., Schäfer, A., Ellen Kuhl, A., & Goriely, A. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110102 · Cited by 62
Lau, H. H. C., Ingelsson, M., & Watts, J. C. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02201-2 · Cited by 57
Fernando, K., & Wijayasinghe, Y. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.746631 · Cited by 57
Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits
Sun, H.-L., Chen, S.-H., Yu, Z.-Y., Cheng, Y., Tian, D.-Y., Fan, D.-Y., He, C.-Y., Wang, J., Sun, P.-Y., Chen, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0842-1 · Cited by 56
Prion-like p53 Amyloids in Cancer
Navalkar, A., Ghosh, S., Pandey, S., Paul, A., Datta, D., & Maji, S. K. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00796 · Cited by 56
Protein amyloid aggregate: Structure and function
Xu, Q., Ma, Y., Sun, Y., Li, D., Zhang, X., & Liu, C. (2023) · Aggregate · doi:10.1002/agt2.333 · Cited by 57
Agosta, F., Weiler, M., & Filippi, M. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12410 · Cited by 56
Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin
Tan, Z., Dai, W., van Erp, T. G. M., Overman, J., Demuro, A., Digman, M. A., Hatami, A., Albay, R., Sontag, E. M., Potkin, K. T., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.81 · Cited by 57
Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
Oueslati, A., Ximerakis, M., & Vekrellis, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.324 · Cited by 58
Aβ “Stretching-and-Packing” Cross-Seeding Mechanism Can Trigger Tau Protein Aggregation
Qi, R., Luo, Y., Wei, G., Nussinov, R., & Ma, B. (2015) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.5b01447 · Cited by 55
Guan, X., Zhang, Y., Wei, H., Guo, T., Zeng, Q., Zhou, C., Wang, J., Gao, T., Xuan, M., Gu, Q., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.013 · Cited by 56
Cyclic Peptides as Inhibitors of Amyloid Fibrillation
Luo, J., & Abrahams, J. P. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201304253 · Cited by 56
Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity
Yen, C., Harischandra, D. S., Kanthasamy, A. G., & Sivasankar, S. (2016) · Science Advances · doi:10.1126/sciadv.1600014 · Cited by 55
Bose, S., & Cho, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.004 · Cited by 56
Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases
Myeku, N., & Duff, K. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.11.006 · Cited by 55
Elongator mutation in mice induces neurodegeneration and ataxia-like behavior
Kojic, M., Gaik, M., Kiska, B., Salerno-Kochan, A., Hunt, S., Tedoldi, A., Mureev, S., Jones, A., Whittle, B., Genovesi, L. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05765-6 · Cited by 56
Molecular structure of an N-terminal phosphorylated β-amyloid fibril
Hu, Z., Vugmeyster, L., Au, D. F., Ostrovsky, D., Sun, Y. P., & Qiang, W. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818530116 · Cited by 55
Mammeri, N. E., Dregni, A. J., Duan, P., & Hong, M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316175121 · Cited by 54
Multifaceted Role of Sialylation in Prion Diseases
Baskakov, I. V., & Katorcha, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00358 · Cited by 54
Distinct Mechanisms Determine α-Synuclein Fibril Morphology during Growth and Maturation
Sidhu, A., Segers‐Nolten, I. M. J., Raussens, V., Claessens, M. M. A. E., & Subramaniam, V. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00287 · Cited by 54
Tavassoly, O., Kakish, J., Nokhrin, S. M., Dmitriev, O. Y., & Lee, J. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.090 · Cited by 55
Ishii, T., Kawakami, E., Endo, K., Misawa, H., & Watabe, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179375 · Cited by 55
Aβ seeding potency peaks in the early stages of cerebral β‐amyloidosis
Ye, L., Rasmussen, J., Kaeser, S. A., Marzesco, A., Obermüller, U., Mahler, J., Schelle, J., Odenthal, J., Krüger, C., Fritschi, S. K., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744067 · Cited by 54
Self-citationTee, B. L., Longoria-Ibarrola, E. M., & Geschwind, M. D. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.07.005 · Cited by 57
Zhang, J., Ji, B., Hu, J., Zhou, C., Li, L., Li, Z., Huang, X., & Hu, X. P. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314567 · Cited by 53
The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
Courade, J., Zetterberg, H., Höglinger, G. U., & Dewachter, I. (2025) · Cell · doi:10.1016/j.cell.2025.11.033 · Cited by 57
Novotny, R., Langer, F., Mahler, J., Skodras, A., Vlachos, A., Wegenast‐Braun, B. M., Kaeser, S. A., Neher, J. J., Eisele, Y. S., Pietrowski, M. J., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0258-16.2016 · Cited by 55
Self-citationCarlson, G. A., & Prusiner, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094861 · Cited by 51
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Wang, R., Ren, H., Kaznacheyeva, E. V., Lu, X., & Wang, G. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00957-z · Cited by 51
Frank, S. A. (2014) · Current Biology · doi:10.1016/j.cub.2014.05.021 · Cited by 51
Prion‐like propagation as a pathogenic principle in frontotemporal dementia
Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 58
Synthesis and characterization of styryl-BODIPY derivatives for monitoring in vitro Tau aggregation
Vedamalai, M., Krishnakumar, V. G., Gupta, S. K., Mori, S., & Gupta, I. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.12.104 · Cited by 51
Age-Dependent Protein Aggregation Initiates Amyloid-β Aggregation
Groh, N., Bühler, A., Huang, C., Li, K. W., van Nierop, P., Smit, A. B., Fändrich, M., Baumann, F., & David, D. C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00138 · Cited by 53
Zhao, T., Hong, Y., Yin, P., Li, S., & Li, X. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710549114 · Cited by 54
Cramer, P. E., Gentzel, R. C., Tanis, K. Q., Vardigan, J. D., Wang, Y., Connolly, B., Manfre, P., Lodge, K. E., Renger, J. J., Zerbinatti, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.011 · Cited by 51
Neuropathology of Animal Prion Diseases
Orge, L., Lima, C., Machado, C., Tavares, P., Mendonça, P., Carvalho, P., Silva, J. P. N., Pinto, M. D. L., Bastos, E., Pereira, J. C., et al. (2021) · Biomolecules · doi:10.3390/biom11030466 · Cited by 55
Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
Tetz, G. V., & Tetz, V. (2021) · Microorganisms · doi:10.3390/microorganisms9061301 · Cited by 50
The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after?
Gabrielli, M., Raffaele, S., Fumagalli, M., & Verderio, C. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.984690 · Cited by 55
Obici, L. P., & Merlini, G. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.922541 · Cited by 49
Gorges, M., Müller, H., Lulé, D. E., Pinkhardt, E. H., Ludolph, A. C., & Kassubek, J. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9367-7 · Cited by 49
Unraveling the mechanism of cell death induced by chemical fibrils
Julien, O., Kampmann, M., Bassik, M. C., Zorn, J. A., Venditto, V. J., Shimbo, K., Agard, N. J., Shimada, K., Rheingold, A. L., Stockwell, B. R., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1639 · Cited by 49
Mitochondrial ROS-mediated post-transcriptional regulation of α-synuclein through miR-7 and miR-153
Je, G., & Kim, Y. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.065 · Cited by 49
Goto, Y., Adachi, M., Muta, H., & So, M. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0370-7 · Cited by 49
Prion-like Domains in Eukaryotic Viruses
Tetz, G. V., & Tetz, V. (2018) · Scientific Reports · doi:10.1038/s41598-018-27256-w · Cited by 50
Barykin, E. P., Petrushanko, I. Y., Kozin, S. A., Telegin, G. B., Чернов, А. С., Lopina, O. D., Radko, S. P., Mitkevich, V. A., & Makarov, A. А. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00302 · Cited by 49
Two-faced behavior of microglia in Alzheimer’s disease
Chen, Y., & Colonna, M. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00963-w · Cited by 51
Natale, F., Fusco, S., & Grassi, C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00326-w · Cited by 49
Mei, L., Chen, X., Wei, F., Huang, X. S., Liu, L., Yao, J., Chen, J., Luo, X., Wang, Z., & Yang, A. (2023) · Autophagy · doi:10.1080/15548627.2023.2234797 · Cited by 50
Supersaturation-limited Amyloid Fibrillation of Insulin Revealed by Ultrasonication
Muta, H., Lee, Y. H., Kardos, J., Lin, Y., Yagi, H., & Goto, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566950 · Cited by 48
Transmission of Neurodegenerative Disorders Through Blood Transfusion
Edgren, G., Hjalgrim, H., Rostgaard, K., Lambert, P. C., Wikman, A. T., Norda, R., Titlestad, K.-E., Erikstrup, C., Ullum, H., Melbye, M., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2421 · Cited by 48
Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids
Macedo, B., & Cordeiro, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051023 · Cited by 48
Model membrane size-dependent amyloidogenesis of Alzheimer's amyloid-β peptides
Kinoshita, M., Kakimoto, E., Terakawa, M. S., Lin, Y., Ikenoue, T., So, M., Sugiki, T., Ramamoorthy, A., Goto, Y., & Lee, Y. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp07774a · Cited by 48
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
Fuster-Matanzo, A., Hernández, F., & Ávila, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030645 · Cited by 50
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Singh, R., Panghal, A., Jadhav, K., Thakur, A., Verma, R. K., Singh, C., Goyal, M., Kumar, J., & Namdeo, A. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04256-8 · Cited by 50
Amyloid-β pathology induced in humans
Jucker, M., & Walker, L. C. (2015) · Nature · doi:10.1038/525193a · Cited by 47
Self-citationUmemoto, A., Yagi, H., So, M., & Goto, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.569814 · Cited by 47
Neurodegeneration and RNA ‐binding proteins
Conti, L. D., Baralle, M., & Buratti, E. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1394 · Cited by 51
Chen, M., Chang, Y., Huang, S., Xiao, L., Zhou, W., Zhang, L., Li, C., Zhou, R., Tang, J., Lin, L., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700281 · Cited by 47
Jan, A. T., Azam, M., Rahman, S., Almigeiti, A. M. S., Choi, D. H., Lee, E. J., Haq, Q. M. R., & Choi, I. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00356 · Cited by 49
Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases
Vanni, S., Zattoni, M., Moda, F., Giaccone, G., Tagliavini, F., Haı̈k, S., Deslys, J., Zanusso, G., Ironside, J. W., Carmona, M., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00008 · Cited by 47
McAllister, B. B., Lacoursiere, S. G., Sutherland, R. J., & Mohajerani, M. H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.026 · Cited by 48
In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model
Sidiqi, A. M., Wahl, D. J., Lee, S., Ma, D., To, E., Cui, J. Z., To, E. C., Beg, M. F., Šarunic, M. V., & Matsubara, J. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00713 · Cited by 49
Lewandowski, D., Foik, A. T., Šmidák, R., Choi, E. H., Zhang, J., Hoang, T. V., Tworak, A., Suh, S., Leinonen, H., Dong, Z., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156301 · Cited by 47
A new prion disease: relationship with central and peripheral amyloidoses
Mead, S., & Reilly, M. M. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.263 · Cited by 46
Identification of novel fluorescent probes preventing PrP Sc replication in prion diseases
Zaccagnini, L., Brogi, S., Brindisi, M., Gemma, S., Chemi, G., Legname, G., Campiani, G., & Butini, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.064 · Cited by 46
Lim, K. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00158 · Cited by 46
Xia, Y., Sorrentino, Z. A., Kim, J. D., Strang, K. H., Riffe, C. J., & Giasson, B. I. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010178 · Cited by 48
Karyopherin abnormalities in neurodegenerative proteinopathies
Pasha, T., Zatorska, A., Sharipov, D., Rogelj, B., Hortobágyi, T., & Hirth, F. (2021) · Brain · doi:10.1093/brain/awab201 · Cited by 51
Tissue‐Scale Biomechanical Testing of Brain Tissue for the Calibration of Nonlinear Material Models
Faber, J., Hinrichsen, J., Greiner, A., Reiter, N., & Budday, S. (2022) · Current Protocols · doi:10.1002/cpz1.381 · Cited by 47
Alpha-synuclein and the prion hypothesis in Parkinson's disease
Melki, R. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.08.002 · Cited by 52
Polyion Complex Micelles for Protein Delivery*
Chen, F., & Stenzel, M. H. (2018) · Australian Journal of Chemistry · doi:10.1071/ch18219 · Cited by 45
Identification of Key Regulatory Genes and Pathways in Prefrontal Cortex of Alzheimer’s Disease
Yang, F., Diao, X., Wang, F., Wang, Q., Sun, J., Zhou, Y., & Xie, J. (2020) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-019-00353-8 · Cited by 45
Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
Jeon, Y., Lee, J., Choi, B., Won, S.-Y., & Cho, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030884 · Cited by 46
So, R. W. L., & Watts, J. C. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168011 · Cited by 46
TDP ‐43 in amyotrophic lateral sclerosis – is it a prion disease?
Ludolph, A. C., & Brettschneider, J. (2015) · European Journal of Neurology · doi:10.1111/ene.12706 · Cited by 45
Smith, L. A., & McMahon, L. L. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.11.014 · Cited by 45
Converging Patterns of α-Synuclein Pathology in Multiple System Atrophy
Brettschneider, J., Suh, E. R., Robinson, J. L., Fang, L., Lee, E. B., Irwin, D. J., Grossman, M., Deerlin, V. M. V., Lee, V. M. ‐., & Trojanowski, J. Q. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly080 · Cited by 45
Metadata
- Authors
- Jucker, M., & Walker, L. C.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Emory University (US)
- Corresponding author
- Jucker, Mathias
- Walker, Lary C.
- Venue
- Nature
- Published
- 2013-09-04
- Volume
- 501
- Issue
- 7465
- Pages
- 45-51
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3963807
- OpenAlex
- W2034147064
- Cited by
- 1,663
- References
- 126
- Citations by year
- 2026: 82 · 2025: 113 · 2024: 114 · 2023: 111 · 2022: 119 · 2021: 161 · 2020: 140 · 2019: 153 · 2018: 131 · 2017: 166 · 2016: 147 · 2015: 119 · 2014: 101 · 2013: 6
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- National Institutes of Health (P51OD011132)
- National Institute on Aging (R21AG040589)
- National Center for Research Resources (P51RR165, P51RR000165)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- protein aggregation, seeded aggregation, neurodegenerative diseases, prion disease, Alzheimer's disease, Parkinson's disease, Creutzfeldt-Jakob disease, protein misfolding, amyloid, oligomers, proteinopathies, disease models, neurodegeneration therapy
- MeSH terms
- Alzheimer Disease, Amyloid, Animals, Humans, Prions, tau Proteins, Prion Diseases, Neurodegenerative Diseases, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
